Login

Hope is not a strategy|Kevin Talbot,Co-Founder & Managing Partner,Relay Ventures 00:10:00

Share On Facebook Share On Twitter

Co-Founder and Managing Partner of Relay Ventures.

Recent Videos

00:10:00
Dryden Gold Secures $20M+ War Chest, Delivers High-Grade Discoveries and Expands Drill Targets Across Gold Rock District|Trey Wasser,CEO & Director,Dryden Gold
00:10:00
Mitchell Services Targets $50–60M EBITDA as Rig Utilization Drives Earnings Upside| Andrew Elf,CEO,Mitchell Services Limited
00:10:00
Lomiko Metals Reports Strong Pre-Feasibility Results with $800M NPV, Advancing High-Growth Graphite Projects|Gordana Slepcev,CEO,Lomiko Metals Inc.4
00:10:00
Generative AI Meets Wet Lab: Absci Accelerates Biologic Development with Hybrid Business Model|Sean McClain,CEO,Absci
00:10:00
Obliva Aims to Transform Lives of Children with Rare Mitochondrial Disorders|Ellen K. Donnelly ,CEO,Abliva AB7
00:10:00
Abionic Repositions Bio-HDL Therapy CCR001 for Rare Kidney and Eye Disorders with Promising Early Results|Cyrille Tupin,CEO,ABIONYX Pharma
00:10:00
Abingdon Health Reports 45% H1 Revenue Growth Amid Strategic Expansion and Large Contract Wins|Dr Chris Hand,Chairman,Abingdon Health
00:10:00
EB-101 Gene Therapy Shows Promising Results in Treating Recessive Dystrophic EB|Vishwas Seshadri,CEO,Abeona Therapeutics
00:10:00
Revolutionizing Trauma Care: How AAP’s Silver Technology is Fighting Deadly Implant Infections|Rubino Di Girolamo,CEO,aap Implantate AG
00:10:00
Revolutionizing Cancer Treatment: Tumor-Agnostic mTOR Targeting Shows Breakthrough Success in Rare and Genetic-Driven Tumors| Neil Desai, Founder, Executive Chairman ,Aadi Bioscience
00:10:00
Millions Affected, No Approved Cure: 89bio Advances New Therapy for NASH|Rohan Palekar,CEO,89bio Inc2
00:10:00
Malaria Prevention Drug Arakoda Positioned to Drive Future Growth for 60 Degrees Pharmaceuticals|Geoffrey Dow,President,60 Degrees Pharmaceuticals
00:10:00
4DMedical Revolutionizes Lung Imaging with CTVQ: Turning a Simple CT Scan into Functional Lung Diagnostics|Dr Andreas Fouras,CEO,4Dmedical Ltd
00:10:00
4DMedical Revolutionizes Lung Imaging with CTVQ: Turning a Simple CT Scan into Functional Lung Diagnostics|Dr Andreas Fouras,CEO,4Dmedical Ltd
00:10:00
4basebio CEO Heikki Lanckriet Unveils Vision for Next-Generation Synthetic DNA and Gene Therapy Components|Heikki Lanckriet,CEO,4basebio
00:10:00
Jim Woody on Leading 180 Life Sciences: Advancing Breakthrough Biologic Therapies for Inflammation, Fibrosis, and Pain|Dr. Jim Woody,CEO,180 Life Sciences

Suggestions

00:10:00
Reflecting on Veterans' Sacrifices: A Tribute from PSP|  Neil Cunningham, CEO, PSP Investments.
00:10:00
Omnes Capital is promoting two Principals and strengthening its Communications & Investor Relations team|Benjamin Arm, Managing Partner, Omnes Capital
00:10:00
Award-winning private equity firm that acquires middlemarket consumer and services companies|Scott Johnson,CEO,SJ Partners
00:10:00
led scalable businesses with a differentiated business model|Linnea Conrad Roberts,Founder and CEO,GingerBread Capital
00:10:00
Lunch Keynote with Charles Penner, JANA Partners LLC at the CEO Investor Forum, April 19 2018 - Charles Penner | Partner | JANA Partners LLC
00:00:00
Imugene Commences new PD1-Vaxx Bowel Cancer Trial - Leslie Chong | CEO & Managing Director, Imugene Ltd
00:10:00
Gold Exploration Funding: Trends, Risks, and Investor Sentiment
00:10:00
Chris Kubasik, CEO of L3Harris Technologies, discussed the company's $4.7 billion bid to merge with Aerojet Rocketdyne, highlighting the strategic benefits and expected synergies from combining their capabilities in missile defense, hypersonics, and advan
00:10:00
Navigating Global Retail Real Estate: Insights from a Transatlantic Perspective|CEO,Acadia Realty Trust
00:10:00
Green Technology Metals' Lithium Project Progress and Future Plans
00:10:00
Technological Innovation and Pragmatic Use in WWII|Victor Davis Hanson
00:10:00
Basin Energy's 2024 Exploration Program Overview and Key Results

© 2017 - Neuhu+